Investigation of Antiangiogenic Tumor Therapy Potential of Microencapsulated HEK293 VEGF<sub>165</sub>b Producing Cells

<table>The quantity of secreted VEGF<sub>165</sub>b from encapsulated and nonencapsulated HEK293 VEGF<sub>165</sub>b producing cells determined by ELISA.</table>

BioMed Research International

fig3

Figure 3

Figure 3: Investigation of Antiangiogenic Tumor Therapy Potential of Microencapsulated HEK293 VEGF<sub>165</sub>b Producing Cells 

BioMed Research International

Investigation of Antiangiogenic Tumor Therapy Potential of Microencapsulated HEK293 VEGF165b Producing Cells

Figure 3

Investigation of Antiangiogenic Tumor Therapy Potential of Microencapsulated HEK293 VEGF₁₆₅b Producing Cells